Stock Screener App

Frei -

Installieren

11.13

2.80% -0.28

Korro Bio Inc (KRRO)

Überblick Nachrichten Preisverlauf Forum Prognose

Korro Bio Inc Aktie (KRRO) Neueste Nachrichten

Korro Bio raises $85 million in private equity financing By Investing.com - Investing.com Nigeria

Korro Bio Stock Gains After Tough 2025New Drug Candidate, Analyst Upgrades Boost Outlook - Sahm

12 Health Care Stocks Moving In Friday's Pre-Market Session - Sahm

RBC Capital Keeps Their Hold Rating on Korro Bio (KRRO) - The Globe and Mail

Analysts Offer Insights on Healthcare Companies: Solid Biosciences (SLDB), Korro Bio (KRRO) and Pharming Group (PHAR) - The Globe and Mail

Analysts Offer Insights on Healthcare Companies: Korro Bio (KRRO), Sagimet Biosciences, Inc. Class A (SGMT) and Bristol-Myers Squibb (BMY) - The Globe and Mail

Analysts Offer Insights on Healthcare Companies: Korro Bio (KRRO), Oruka Therapeutics (ORKA) and Gilead Sciences (GILD) - The Globe and Mail

Analysts Are Bullish on These Healthcare Stocks: Korro Bio (KRRO), Health Catalyst (HCAT) - The Globe and Mail

Korro Bio (KRRO) Losses Of US$117.3 Million Test Bullish Narratives On Profitability - simplywall.st

Korro Bio (KRRO) sellers register 7.65M common shares after $85M private placement - Stock Titan

Cantor Fitzgerald raises Korro Bio stock price target on UCD confidence - Investing.com Canada

Raymond James upgrades Korro Bio stock rating on hyperammonemia pivot - Investing.com Nigeria

Raymond James upgrades Korro Bio stock rating on hyperammonemia pivot By Investing.com - Investing.com UK

Insider Buying: New Enterprise Associates 17, L.P. Acquires Addi - GuruFocus

Korro Bio, Inc. (KRRO) Reports Q4 Loss, Lags Revenue Estimates - sharewise.com

Nea 17 buys Korro Bio (KRRO) shares worth $2.3 million - Investing.com

Korro Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update - Bitget

Korro Bio investor buys $2.3 million in KRRO stock By Investing.com - Investing.com

Advancing Genetic Medicines with RNA Editing: Inside the OPERA Platform and Therapeutic Strategies - Minichart

Korro Bio, Inc. (KRRO) reports Q4 loss, lags revenue estimates - MSN

Baskett Forest buys Korro Bio (KRRO) shares worth $2.3 million - Investing.com

Nea 17 buys Korro Bio (KRRO) shares worth $2.3 million By Investing.com - Investing.com South Africa

Korro Bio (KRRO) major holder adds stock and pre-funded warrants in March 2026 buy - Stock Titan

Insider fund tied to Carmen Chang boosts Korro Bio (KRRO) stake with 450,045 buys - Stock Titan

Korro 10-K: $6.4M Collaboration Revenue; $(12.48) EPS on $(117.3)M Net Loss - TradingView

Korro Bio, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com

Korro Bio (NASDAQ: KRRO) expands RNA-editing pipeline as 2025 net loss deepens - Stock Titan

Korro Bio, Inc. (KRRO) Announces Fourth Quarter Loss, Falls Short of Revenue Expectations - Bitget

Korro shares jump 17% following $85M private placement financing - MSN

Korro Bio (KRRO) Projected to Post Quarterly Earnings on Tuesday - MarketBeat

Korro Secures $85M Lifeline After Trial Setback - National Today

Korro Bio Raises $85 Million in Oversubscribed PIPE Financing to Advance RNA Editing Therapies and Extend Cash Runway into 2028 - Minichart

Korro Bio extends cash runway after trial fail, layoffs - The Business Journals

Korro Announces $85 Million Private Placement - citybiz

Korro Bio prices 4.5M shares at $11.11 in private placement - TipRanks

Korro Announces Oversubscribed $85 Million Private Placement - Bitget

Korro Bio Announces Oversubscribed $85M PIPE Financing - TipRanks

Korro stock surges 17% on $85M private placement financing By Investing.com - Investing.com India

Korro Bio raises $85 million in private equity financing - Investing.com

Korro Bio Raises $85 Million in Private Placement, Adds Investor Registration Rights - TradingView

Korro stock surges 17% on $85M private placement financing - Investing.com

Korro Bio (KRRO) secures $85M PIPE to extend cash runway into 2028 - Stock Titan

Investors pour $85M into RNA editor Korro Bio’s genetic disease drugs - Stock Titan

Korro Bio, Inc. $KRRO Stock Position Raised by JPMorgan Chase & Co. - MarketBeat

Bond Watch: Does Korro Bio Inc have pricing powerJuly 2025 Reactions & Long-Term Safe Investment Plans - baoquankhu1.vn

Winners Losers: Should you avoid Korro Bio Inc stock right nowWeekly Earnings Recap & Reliable Volume Spike Trade Alerts - baoquankhu1.vn

Korro Bio, Inc. (NASDAQ:KRRO) Receives Consensus Rating of “Hold” from Analysts - Defense World

KRRO Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

KRRO Stock News Today | Earnings, Events & Price Alerts - Intellectia AI

Bond Watch: What is the next catalyst for Korro Bio IncTrade Volume Report & Precise Swing Trade Alerts - baoquankhu1.vn

Profit Recap: Will Korro Bio Inc benefit from green energy policiesQuarterly Market Summary & Breakout Confirmation Trade Signals - baoquankhu1.vn

Korro Bio (KRRO) price target increased by 12.61% to 19.53 - MSN

RVMD

$99.42

1.41%

ROIV

$27.73

0.27%

MRNA

$52.36

0.29%

BNTX

$88.25

1.94%

INSM

$143.68

0.71%

ONC

$283.12

0.05%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters